Late Breaking Abstract - Short-acting ß2-agonist use in asthma in Western societies
J. Quint (London, United Kingdom), S. Arnetorp (Gothenburg, Sweden), C. Janson (Uppsala, Sweden), S. Boarino (Milan, Italy), J. Kocks (Groningen, Netherlands), I. Gilbert (Wilmington, DE, United States of America), M. Kupczyk (Lodz, Poland), J. Nuevo (Madrid, Spain), N. Lucia Lugogo (Ann Arbor, MI, United States of America), E. Penz (Saskatoon, Saskatchewan, Canada), S. Quirce (Madrid, Spain), C. Raherison-Semjen (Bordeaux, France), R. Van Der Valk (Cambridge, United Kingdom)
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Quint (London, United Kingdom), S. Arnetorp (Gothenburg, Sweden), C. Janson (Uppsala, Sweden), S. Boarino (Milan, Italy), J. Kocks (Groningen, Netherlands), I. Gilbert (Wilmington, DE, United States of America), M. Kupczyk (Lodz, Poland), J. Nuevo (Madrid, Spain), N. Lucia Lugogo (Ann Arbor, MI, United States of America), E. Penz (Saskatoon, Saskatchewan, Canada), S. Quirce (Madrid, Spain), C. Raherison-Semjen (Bordeaux, France), R. Van Der Valk (Cambridge, United Kingdom). Late Breaking Abstract - Short-acting ß2-agonist use in asthma in Western societies. 2629
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: